Global Desmopressin Acetate Market Overview:
Desmopressin is a drug that is used to reduce the amount of urine produced and the frequency with which it is produced. In children, desmopressin acetate is effective in avoiding overnight bedwetting. Desmopressin acetate is prescribed for patients whose bodies do not produce enough vasopressin, the hormone that regulates urine output. Reduced vasopressin production can be caused by a variety of circumstances, including brain surgery or a head injury. Desmopressin operates in a variety of ways, including limiting thirst, frequency of urination, amount of urine produced, and so on. Patients with diabetes insipidus, often known as water diabetes, may benefit from the drug. The market for desmopressin acetate is predicted to expand due to the rising prevalence of diabetes insipidus around the world. The market is projected to develop further as people become more aware of desmopressin acetate's availability. Manufacturers of desmopressin acetate are projected to expand their regional product footprint, as well as engage in various promotional efforts such as public awareness campaigns on how to prevent nocturnal bedwetting, diabetes insipidus treatment, and so on.
- The Rising Prevalence of Diabetes
- Increase in Bedwetting Episodes in Children
- Stringent Regulatory Factors
- Increasing Investment in Healthcare
- Growing Research and Development Activities
- Side Effects Related to Drug
Some of the key players profiled in the report are Ferring Pharmaceuticals Inc. (United States), American Regent Inc.(United States), Sun Pharmaceutical Industries Ltd(India), Teva Pharmaceutical Industries Ltd. (Israel), Glenmark Pharmaceuticals(India), Mylan N.V.(United States), Pfizer(United States), Dr. Reddy's Laboratories (India), BluePoint Laboratories (Ireland) and Sanofi (France). Analyst at AMA Research see United States Players to retain maximum share of Global Desmopressin Acetate market by 2026. Considering Market by Route of Administration, the sub-segment i.e. Oral will boost the Desmopressin Acetate market. Considering Market by Distribution Channel, the sub-segment i.e. Retail Pharmacies will boost the Desmopressin Acetate market.
May 2020 – Dr. Reddy's Laboratories announced the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection, 4 mcg/mL, approved by the U. S.Food and Drug Administration (USFDA).
What Can be Explored with the Desmopressin Acetate Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Desmopressin Acetate Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Desmopressin Acetate
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Desmopressin Acetate market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Desmopressin Acetate market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Desmopressin Acetate, Suppliers of Desmopressin Acetate, Pharmaceutical Companies, Hospitals and Regulatory Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Desmopressin Acetate Market?
The Desmopressin Acetate market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Desmopressin Acetate Market?
Top performing companies in the Global Desmopressin Acetate market are Ferring Pharmaceuticals Inc. (United States), American Regent Inc.(United States), Sun Pharmaceutical Industries Ltd(India), Teva Pharmaceutical Industries Ltd. (Israel), Glenmark Pharmaceuticals(India), Mylan N.V.(United States), Pfizer(United States), Dr. Reddy's Laboratories (India), BluePoint Laboratories (Ireland) and Sanofi (France), to name a few.
3. What trending factors would impact Desmopressin Acetate Market growth most?
"Efforts to increase awareness by various childcare non-profit organizations" is seen as one of major influencing trends for Desmopressin Acetate Market during projected period 2020-2026.